221 related articles for article (PubMed ID: 2832150)
1. Driven by the same Ig enhancer and SV40 T promoter ras induced lung adenomatous tumors, myc induced pre-B cell lymphomas and SV40 large T gene a variety of tumors in transgenic mice.
Suda Y; Aizawa S; Hirai S; Inoue T; Furuta Y; Suzuki M; Hirohashi S; Ikawa Y
EMBO J; 1987 Dec; 6(13):4055-65. PubMed ID: 2832150
[TBL] [Abstract][Full Text] [Related]
2. Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas.
Tran PT; Fan AC; Bendapudi PK; Koh S; Komatsubara K; Chen J; Horng G; Bellovin DI; Giuriato S; Wang CS; Whitsett JA; Felsher DW
PLoS One; 2008 May; 3(5):e2125. PubMed ID: 18461184
[TBL] [Abstract][Full Text] [Related]
3. Experimental model for MDS-like myelodysplasia in transgenic mice harboring the SV40 large-T antigen under an immunoglobulin enhancer.
Inoue T; Hirabayashi Y; Mitsui H; Furuta Y; Suda Y; Aizawa S; Ikawa Y
Leukemia; 1994 Apr; 8 Suppl 1():S202-5. PubMed ID: 8152293
[TBL] [Abstract][Full Text] [Related]
4. Induction of a variety of tumors by c-erbB2 and clonal nature of lymphomas even with the mutated gene (Val659----Glu659).
Suda Y; Aizawa S; Furuta Y; Yagi T; Ikawa Y; Saitoh K; Yamada Y; Toyoshima K; Yamamoto T
EMBO J; 1990 Jan; 9(1):181-90. PubMed ID: 2153076
[TBL] [Abstract][Full Text] [Related]
5. Tumorigenesis in mice with an SV40 T antigen transgene driven by the immunoglobulin gamma 1 heavy chain germline promoter.
Dunnick W; Elenich L; Cunningham K; Chrisp C; Claflin L
Curr Top Microbiol Immunol; 1995; 194():163-9. PubMed ID: 7895490
[No Abstract] [Full Text] [Related]
6. SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice.
Palmiter RD; Chen HY; Messing A; Brinster RL
Nature; 1985 Aug 1-7; 316(6027):457-60. PubMed ID: 2991771
[TBL] [Abstract][Full Text] [Related]
7. Expression of the c-myc oncogene under control of an immunoglobulin enhancer in E mu-myc transgenic mice.
Alexander WS; Schrader JW; Adams JM
Mol Cell Biol; 1987 Apr; 7(4):1436-44. PubMed ID: 3037318
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic co-operation in beta-cell tumorigenesis.
Pelengaris S; Khan M
Endocr Relat Cancer; 2001 Dec; 8(4):307-14. PubMed ID: 11733227
[TBL] [Abstract][Full Text] [Related]
9. Requirement for the simian virus 40 small tumor antigen in tumorigenesis in transgenic mice.
Choi YW; Lee IC; Ross SR
Mol Cell Biol; 1988 Aug; 8(8):3382-90. PubMed ID: 2850490
[TBL] [Abstract][Full Text] [Related]
10. IgH enhancer-mediated deregulation of N-myc gene expression in transgenic mice: generation of lymphoid neoplasias that lack c-myc expression.
Dildrop R; Ma A; Zimmerman K; Hsu E; Tesfaye A; DePinho R; Alt FW
EMBO J; 1989 Apr; 8(4):1121-8. PubMed ID: 2501083
[TBL] [Abstract][Full Text] [Related]
11. Simian virus 40 large T antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice.
Wikenheiser KA; Clark JC; Linnoila RI; Stahlman MT; Whitsett JA
Cancer Res; 1992 Oct; 52(19):5342-52. PubMed ID: 1394139
[TBL] [Abstract][Full Text] [Related]
12. p53 mutations are not selected for in simian virus 40 T-antigen-induced tumors from transgenic mice.
Moore M; Teresky AK; Levine AJ; Seiberg M
J Virol; 1992 Feb; 66(2):641-9. PubMed ID: 1370552
[TBL] [Abstract][Full Text] [Related]
13. The transgenic window on lymphoid malignancy.
Adams JM; Harris AW; Vaux DL; Alexander WS; Rosenbaum H; Klinken SP; Strasser A; Bath ML; McNeall J; Cory S
Princess Takamatsu Symp; 1989; 20():297-309. PubMed ID: 2518688
[TBL] [Abstract][Full Text] [Related]
14. Active ras and myc oncogenes can be compatible, but Sv40 large T antigen is specifically suppressed with normal differentiation of mouse embryonic stem cells.
Suda Y; Hirai S; Suzuki M; Ikawa Y; Aizawa S
Exp Cell Res; 1988 Sep; 178(1):98-113. PubMed ID: 2457506
[TBL] [Abstract][Full Text] [Related]
15. Renin-promoter SV40 large T-antigen transgenes induce tumors irrespective of normal cellular expression of renin genes.
Sola C; Tronik D; Dreyfus M; Babinet C; Rougeon F
Oncogene Res; 1989; 5(2):149-53. PubMed ID: 2558335
[TBL] [Abstract][Full Text] [Related]
16. Brain tumours and lymphomas in transgenic mice that carry HTLV-I LTR/c-myc and Ig/tax genes.
Benvenisty N; Ornitz DM; Bennett GL; Sahagan BG; Kuo A; Cardiff RD; Leder P
Oncogene; 1992 Dec; 7(12):2399-405. PubMed ID: 1461648
[TBL] [Abstract][Full Text] [Related]
17. Multistep hepatocarcinogenesis in transgenic mice harboring SV40 T-antigen gene.
Kitagawa T; Hino O; Lee GH; Li H; Liu J; Nomura K; Ohtake K; Furuta Y; Aizawa S
Princess Takamatsu Symp; 1991; 22():349-60. PubMed ID: 1668891
[TBL] [Abstract][Full Text] [Related]
18. IgH enhancer deregulated expression of L-myc: abnormal T lymphocyte development and T cell lymphomagenesis.
Möröy T; Fisher P; Guidos C; Ma A; Zimmerman K; Tesfaye A; DePinho R; Weissman I; Alt FW
EMBO J; 1990 Nov; 9(11):3659-66. PubMed ID: 2120050
[TBL] [Abstract][Full Text] [Related]
19. Lymphomagenesis in E mu-myc transgenic mice can involve ras mutations.
Alexander WS; Bernard O; Cory S; Adams JM
Oncogene; 1989 May; 4(5):575-81. PubMed ID: 2657573
[TBL] [Abstract][Full Text] [Related]
20. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene.
Sepulveda AR; Finegold MJ; Smith B; Slagle BL; DeMayo JL; Shen RF; Woo SL; Butel JS
Cancer Res; 1989 Nov; 49(21):6108-17. PubMed ID: 2551499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
